These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4758839

  • 1. Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.
    Rein MF, Westervelt FB, Sande MA.
    Antimicrob Agents Chemother; 1973 Sep; 4(3):366-71. PubMed ID: 4758839
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of cefazolin in normal and uremic subjects.
    Welling PG, Craig WA, Gordon AL, Kunin CM.
    Clin Pharmacol Ther; 1974 Apr; 15(4):344-53. PubMed ID: 4821438
    [No Abstract] [Full Text] [Related]

  • 3. Cefazolin plasma concentrations and urinary excretion in patients with renal impairment.
    Czerwinski AW, Pederson JA, Barry JP.
    J Clin Pharmacol; 1974 Oct; 14(10):560-6. PubMed ID: 4430733
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A, Canonne MA, Fillastre JP, Humbert G.
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bactericidal activity and pharmacology of cefazolin.
    Bergeron MG, Brusch JL, Barza M, Weinstein L.
    Antimicrob Agents Chemother; 1973 Oct; 4(4):396-401. PubMed ID: 4598612
    [Abstract] [Full Text] [Related]

  • 7. Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
    Cahn MM, Levy EJ, Actor P, Pauls JF.
    J Clin Pharmacol; 1974 Jan; 14(1):61-6. PubMed ID: 4588120
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The course of serum levels of a new cephalosporin, cephacetrile, as a function of renal elimination capacity].
    Brogard JM, Ruscher H, Frankhauser J, Kuntzmann F, Lavillaureix J.
    Arzneimittelforschung; 1974 Sep; 24(9b):1491-7. PubMed ID: 4479810
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM, Pinget M, Brandt C, Lavillaureix J.
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.
    Humbert G, Leroy A, Fillastre JP, Oksenhendler G.
    Antimicrob Agents Chemother; 1978 Jul; 14(1):40-4. PubMed ID: 686708
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and laboratory evaluation of cefazolin: a new cephalosporin antibiotic in pediatric patients.
    Khan AJ.
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):727-33. PubMed ID: 4201317
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A, Humbert G, Fillastre JP.
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of cephanone in healthy adult volunteers.
    Regamey C, Kirby WM.
    Antimicrob Agents Chemother; 1973 Dec; 4(6):589-92. PubMed ID: 4793878
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
    Ohkawa M, Tokunaga S, Sugata T, Shimamura M, Okasho A, Hirano S, Matsui H.
    Chemotherapy; 1989 Dec; 35(6):416-22. PubMed ID: 2612231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.